New research is shedding light on the intricate connection between smoking and an increased risk of dementia, a link previously established by studies showing heavy midlife smoking can more than double the risk of developing conditions like Alzheimer's disease decades later. A groundbreaking study from the University of Chicago now proposes a specific biological pathway, triggered by nicotine, that helps explain this profound connection.

Researchers discovered that specialized lung cells, known as pulmonary neuroendocrine cells (PNECs), react to nicotine by releasing tiny particles called exosomes. These exosomes then travel to the brain and interfere with its crucial iron regulation processes, which are essential for the health and function of nerve cells. When the brain's iron balance is disrupted, it can lead to damage to neurons, induce stress on their energy systems, and contribute to the very processes linked to neurodegenerative diseases, including Alzheimer's and Parkinson's. According to co-author and postdoctoral researcher Kui Zhang, "This research establishes a clear 'lung-brain' axis that may help explain why cigarette smoking is linked to cognitive decline."

The study, published in Science Advances, utilized laboratory models and stem-cell-derived PNECs. While the findings are promising, the researchers emphasize the need for further studies to confirm this specific mechanism in humans. Co-author Asst. Prof. Joyce Chen highlighted that "The lung is not just a passive target of smoke exposure, but an active signalling organ influencing brain health." The research team is now actively exploring potential therapeutic avenues, such as blocking these exosomes, to protect the brain from the damage induced by smoke.

In a related public health context, Britain has seen its smoking rate fall to a record low, with 9.1 percent of adults, approximately 4.9 million people, smoking in 2024. However, this progress is decelerating, and some regions are experiencing concerning reversals in these declining trends. Concurrently, the use of e-cigarettes has significantly increased, with an estimated 5.4 million adults now vaping, marking the first time vaping has surpassed smoking in the UK, particularly among younger adults.

Public health experts caution that a reduction in traditional cigarette sales does not always directly translate into a proportional drop in overall smoking rates, as individuals may transition to vaping or resort to non-legal tobacco products. To accelerate progress and address these evolving challenges, ministers are advancing the proposed Tobacco and Vapes Bill.

This landmark legislation aims to create a 'smoke-free generation' by legally prohibiting the sale of tobacco to anyone born on or after January 1, 2009. Additionally, the bill includes comprehensive measures to tighten controls on vaping, proposing restrictions on advertising, available flavours, and product packaging to curb its appeal, especially among young people. The proposals have garnered significant support from over 1,200 health professionals, including doctors, nurses, and public health leaders, who deem them essential for reducing smoking prevalence and preventing a new generation from becoming addicted to nicotine.